Illumina | ILMN - Pre Tax Profit


Illumina reported $220M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Agilent USD 442M 1000K Sep/2025
Bio Techne USD 84.99M 107.85M Sep/2025
Bio-Rad Laboratories USD 82.9M 331.1M Sep/2025
Boston Scientific USD 700M 238M Dec/2025
Bruker USD -72.6M 73.1M Sep/2025
Charles River Laboratories USD 170.03M 98.62M Sep/2025
Danaher USD 1.24B 138M Mar/2026
Dentsply International USD -230M 77M Sep/2025
Edwards Lifesciences USD 348.4M 51.8M Sep/2025
Illumina USD 220M 86M Sep/2025
Intuitive Surgical USD 955.6M 100.4M Dec/2025
IQVIA Holdings USD 537M 5.62B Dec/2025
Laboratory Of America USD 337M 32.3M Sep/2025
Mettler Toledo International USD 269.24M 20.58M Sep/2025
Myriad Genetics USD 4.6M 3.4M Dec/2025
OraSure Technologies USD -18.43M 5.14M Dec/2025
Pacific Biosciences Of California USD -40.17M 2.55M Dec/2025
Quest Diagnostics USD 334M 4M Mar/2026
Quidel USD -756.9M 527.3M Sep/2025
Repligen USD 17.11M 10.25M Sep/2025
Revvity USD 55.68M 115.97M Sep/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Standard Biotools USD -22.03M 10.87M Dec/2025
Thermo Fisher Scientific USD 2.12B 295M Dec/2025
Waters USD 170.12M 7.57M Sep/2025